Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.08
-0.09 (-1.32%)
Apr 29, 2026, 2:14 PM EDT - Market open

Unicycive Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-26.56-36.73-30.54-18.06-10.02
Upgrade
Depreciation & Amortization
0.570.430.280.160.01
Upgrade
Other Amortization
----0.49
Upgrade
Asset Writedown & Restructuring Costs
----2.19
Upgrade
Stock-Based Compensation
2.642.351.771.051.11
Upgrade
Other Operating Activities
-2.025.810.30.020.55
Upgrade
Change in Accounts Payable
-2.510.791.281.271.24
Upgrade
Change in Other Net Operating Assets
-3.45-1.22-1.37-0.09-1.35
Upgrade
Operating Cash Flow
-31.32-28.58-18.28-15.65-5.77
Upgrade
Capital Expenditures
-0.02-0.07-0.01-0-0.03
Upgrade
Investment in Securities
-12.07----
Upgrade
Investing Cash Flow
-12.1-0.07-0.01-0-0.03
Upgrade
Short-Term Debt Issued
----1.35
Upgrade
Total Debt Issued
----1.35
Upgrade
Short-Term Debt Repaid
-----1.36
Upgrade
Total Debt Repaid
-----1.36
Upgrade
Net Debt Issued (Repaid)
-----0.02
Upgrade
Issuance of Common Stock
48.080.68-0.0122.39
Upgrade
Preferred Dividends Paid
--1.1---
Upgrade
Dividends Paid
--1.1---
Upgrade
Other Financing Activities
-1.61-4.5-2.65-0.48-
Upgrade
Financing Cash Flow
46.4745.0927.54-0.4722.38
Upgrade
Net Cash Flow
3.0616.449.25-16.1216.58
Upgrade
Free Cash Flow
-31.34-28.65-18.3-15.65-5.8
Upgrade
Free Cash Flow Margin
---2710.37%-1645.95%-
Upgrade
Free Cash Flow Per Share
-1.97-4.28-7.46-10.40-4.96
Upgrade
Cash Interest Paid
-0.010.020.01-
Upgrade
Levered Free Cash Flow
-22.92-12.171.57-9.26-4.6
Upgrade
Unlevered Free Cash Flow
-22.88-12.131.62-9.26-4.7
Upgrade
Change in Working Capital
-5.95-0.43-0.091.18-0.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.